Literature DB >> 6970051

Patterns of cell proliferation and cell migration in the Sézary syndrome.

P A Bunn, R Edelson, S S Ford, S E Shackney.   

Abstract

The patterns of cell proliferation and cell migration were studied in three patients with the Sezary syndrome using autoradiographic techniques. Cell labeling patterns following pulse labeling with tritiated thymidine in vivo indicated that Sezary cells proliferate actively in skin and in lymph nodes but that few if any Sezary cells proliferate in the peripheral blood. In two of the patients serial samples were obtained. Label dilution patterns in skin and blood over time suggested that circulating Sezary cells originated in extracutaneous sites where cells were proliferating more rapidly than in the skin. Cells labeled in extracutaneous sites of proliferation appear rapidly in the blood, and their transit time through the peripheral blood compartment is short. Circulating Sezary cells may then be deposited in the skin where they resume proliferation at a low rate. Thus, while Sezary cells proliferate in both cutaneous and extracutaneous sites, proliferation appears to be more rapid in extracutaneous sites such as lymph nodes. This suggests that trials of systemic therapeutic approaches should be undertaken.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6970051

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

1.  Fluorescent staining of the actin cytoskeleton in human lymphocytes, monocytes and polymorphonuclear cells using a DNAse 1/anti-DNAse 1 immunoglobulin fluorescein conjugated system.

Authors:  P J Philip; I Sudaka; B Mely-Goubert
Journal:  Histochemistry       Date:  1992

2.  Intraepidermal but not dermal T lymphocytes are positive for a cell-cycle-associated antigen (Ki-67) in mycosis fungoides.

Authors:  B J Nickoloff; C E Griffiths
Journal:  Am J Pathol       Date:  1990-02       Impact factor: 4.307

3.  Aurora Kinase A Is Upregulated in Cutaneous T-Cell Lymphoma and Represents a Potential Therapeutic Target.

Authors:  Daniel Humme; Ahmed Haider; Markus Möbs; Hiroshi Mitsui; Mayte Suárez-Fariñas; Hanako Ohmatsu; Cyprienne Isabell Geilen; Jürgen Eberle; James G Krueger; Marc Beyer; Michael Hummel; Ioannis Anagnostopoulos; Wolfram Sterry; Chalid Assaf
Journal:  J Invest Dermatol       Date:  2015-04-07       Impact factor: 8.551

4.  Interleukin-7 is a growth factor for Sézary lymphoma cells.

Authors:  A Dalloul; L Laroche; M Bagot; M D Mossalayi; C Fourcade; D J Thacker; D E Hogge; H Merle-Béral; P Debré; C Schmitt
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

5.  Sézary syndrome with hyposplenism.

Authors:  W J Pichler; H H Peter; J Anagnou; F J Kaup; W Drommer
Journal:  Blut       Date:  1984-08

6.  Predominant cutaneous infiltration by OKT6- and OKT8-positive cells in a case of Sézary syndrome.

Authors:  K Meissner; T Löning; M Heckmayr; R Zschaber; M Jänner
Journal:  Arch Dermatol Res       Date:  1983       Impact factor: 3.017

7.  Lack of suppressive CD4+CD25+FOXP3+ T cells in advanced stages of primary cutaneous T-cell lymphoma.

Authors:  Machteld M Tiemessen; Tracey J Mitchell; Lisa Hendry; Sean J Whittaker; Leonie S Taams; Susan John
Journal:  J Invest Dermatol       Date:  2006-06-01       Impact factor: 8.551

8.  Blood and skin-derived Sezary cells: differences in proliferation-index, activation of PI3K/AKT/mTORC1 pathway and its prognostic relevance.

Authors:  Cristina Cristofoletti; Antonella Bresin; Mario Picozza; Maria Cristina Picchio; Francesca Monzo; Mauro Helmer Citterich; Francesca Passarelli; Alessandra Frezzolini; Enrico Scala; Alessandro Monopoli; Maria Cantonetti; Roberto Benucci; Stefania D'Atri; Elisabetta Caprini; Giandomenico Russo; Maria Grazia Narducci
Journal:  Leukemia       Date:  2018-12-05       Impact factor: 11.528

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.